Skip to main content

Table 2 Basic clinical and epidemic features based on antiviral drugs usage (four groups)

From: Clinical features and efficacy of antiviral drug, Arbidol in 220 nonemergency COVID‐19 patients from East-West-Lake Shelter Hospital in Wuhan: a retrospective case series

Feature

Control (n = 45)

Other antiviral drugs (n = 45)

Arbidol only (n = 90)

Arbidol + other antiviral drugs (n = 40)

Age [years, M (IQR)]a

51 (40, 61)

52 (45, 59)

48 (36, 56)

51 (38, 58)

 > 50 years (%)

25 (55.6)

27 (60.0)

39 (43.3)

20 (50.0)

 Male (%)

22 (48.9)

25 (55.6)

52 (57.8)

20 (50.0)

Underlying disease (%)b

7 (15.6)

9 (20.0)

13 (14.4)

14 (35.0)

Onset symptoms

 Fever (%)

27 (60.0)

37 (82.2)

77 (85.6)

35 (87.5)

 Less than 3 onset symptoms (%)c

29 (64.4)

23 (51.1)

57 (63.3)

25 (62.5)

Lab examination

 WBC (× 109/ L, M (IQR))

5.3 (4.5, 6.2)

4.9 (4.3, 6.1)

5.4 (4.4, 6.5)

5.7 (4.1, 7.2)

Neutrophils % [M (IQR)]

65.5 (57.2, 70.3)

66.5 (61.5, 69.3)

62.8 (55.9, 71.1)

65.3 (54.4, 73.9)

Lymphocyte % [M (IQR)]

22.0 (16.9, 27.8)

24.6 (20.4, 29.1)

23.1 (17.6, 32.2)

24.2 (18.0, 32.7)

Platelet [× 109/L, M (IQR)]

167.0 (143.0, 234.0)

160.0 (130.8, 201.8)

165.0 (142.5, 209.5)

179.0 (150.5, 232.5)

CT findings

 Lung region distribution

  Unilateral (%)

1 (2.2)

1 (2.2)

1 (1.1)

0 (0.0)

  Bilateral (%)

44 (97.8)

44 (97.8)

89 (98.9)

39 (97.5)

  Absence of lesion (%)

0 (0.0)

0 (0.0)

0 (0.0)

1 (2.5)

 Lesions feature

  GGOsd

18 (40.0)

19 (42.2)

41 (45.5)

24 (60.0)

  Scattered patchy infiltration with interstitial alteration

18 (40.0)

21 (46.7)

24 (26.7)

8 (20.0)

  Consolidation

1 (2.2)

1 (2.2)

7 (7.8)

0 (0.0)

  More than one feature

8 (17.8)

4 (8.9)

18 (20.0)

7 (17.5)

 Other antiviral drugs

  Oseltamivir (%)

0 (0.0)

41 (91.2)

0 (0.0)

39 (97.5)

  Ribavirin (%)

0 (0.0)

1 (2.2)

0 (0.0)

1 (2.5)

  Ganciclovir (%)

0 (0.0)

1 (2.2)

0 (0.0)

0 (0.0)

  Prezcobix (%)

0 (0.0)

1 (2.2)

0 (0.0)

0 (0.0)

  Oseltamivir + Ribavirin (%)

0 (0.0)

1 (2.2)

0 (0.0)

0 (0.0)

 Other treatments except for antiviral drugs

  Antibiotics

23 (51.1)

31 (68.9)

57 (63.3)

28 (70.0)

  Chinese medicine (Lian Hua Qing Wen)

36 (80.0)

36 (80.0)

73 (81.1)

35 (87.5)

  Methylprednisolone

0 (0.0)

1 (2.2)

1 (1.1)

0 (0.0)

  Gamma immunoglobulin

1 (2.2)

0 (0.0)

2 (2.2)

0 (0.0)

  1. aM(IQR) medium (inter quartile range)
  2. bIncluding diabetes mellitus, high blood pressure, coronary heart disease, congestive heart failure, chronic kidney disease, chronic obstructive pulmonary disease, asthma, chronic liver disease, history of breast cancer, gout, rheumatoid arthritis and retrobulbar duodenal ulcer
  3. cIncluding dry cough, expectoration, chest tightness and shortness of breath, fatigue, muscle soreness, stuffy running nose, headache, pharyngalgia, thoracalgia, dyspnea, phlegm blood, chills and poor appetite
  4. dGGOs ground-glass opacity